Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease

被引：0
|
作者：
Sharon Rikin
Stephanie Deccy
Chenshu Zhang
Jill Crandall
Yuting Deng
Ladan Golestaneh
机构：
[1] Montefiore Medical Center and Albert Einstein College of Medicine,Division of General Internal Medicine
[2] Montefiore Medical Center and Albert Einstein College of Medicine,undefined
来源：
Journal of General Internal Medicine | 2023年 / 38卷
关键词：
chronic kidney disease; evidence-based medicine; diabetes mellitus; sodium-glucose cotransporter-2 inhibitor; renin and angiotensin system inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1599 / 1605
页数：6
相关论文
共 50 条
  • [1] Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease
    Rikin, Sharon
    Deccy, Stephanie
    Zhang, Chenshu
    Crandall, Jill
    Deng, Yuting
    Golestaneh, Ladan
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (07) : 1599 - 1605
  • [2] Kidney Outcomes with Sodium-Glucose Cotransporter-2 Inhibitor Initiation after AKI among Veterans with Diabetic Kidney Disease
    Murphy, Daniel P.
    Wolfson, Julian
    Reule, Scott
    Johansen, Kirsten L.
    Ishani, Areef
    Drawz, Paul E.
    KIDNEY360, 2024, 5 (03): : 335 - 343
  • [3] Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor
    Koch, Richard A.
    Clark, Richard F.
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (05) : E590 - E591
  • [4] Sodium-glucose cotransporter-2 inhibitor prescribing practices
    Alcorn, Chris
    Subarajan, Prathayini
    Kesari, Aditya
    Lockhart, Marie
    Cottrell, Daryl
    Jordan, Kim
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1136 - 1139
  • [5] Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor
    Zhang, Lydia
    Tamilia, Michael
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (25) : E766 - E768
  • [6] Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients
    Maigret, Lucie
    Basle, Lucile
    Chatelet, Valerie
    Ecotiere, Laure
    Perrin, Peggy
    Golbin, Leonard
    Bertrand, Dominique
    Anglicheau, Dany
    Poulain, Coralie
    Garrouste, Cyril
    Danthu, Clement
    Boud'hors, Charlotte
    Le Meur, Yannick
    Dekeyser, Manon
    Duthe, Fabien
    Sautenet, Benedicte
    Deliege, Pierre-Guillaume
    Gatault, Philippe
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (03): : 816 - 827
  • [7] Sodium-glucose cotransporter-2 inhibitor use in patients with a Fontan circulation
    Gaydos, Stephanie S.
    Mchugh, Kimberly E.
    Woodard, Frances K.
    Judd, Rochelle N.
    Brenzel, Thomas J.
    Henderson, Heather T.
    Savage, Andrew J.
    Atz, Andrew M.
    Gregg, David
    CARDIOLOGY IN THE YOUNG, 2025,
  • [8] Use of Sodium-Glucose Cotransporter-2 Inhibitor for Diabetes Management in Patients Following Kidney Transplantation
    Crannage, Erica F.
    Nguyen, Katherine L.
    Ellebrecht, Morgan D.
    Challen, Laura M.
    Crannage, Andrew J.
    JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (03) : 147 - 155
  • [9] Emerging sodium-glucose cotransporter-2 inhibitor therapies for managing heart failure in patients with chronic kidney disease
    Chan, Jeffrey Shi Kai
    Perone, Francesco
    Bayatpoor, Yasmin
    Tse, Gary
    Harky, Amer
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (08) : 935 - 945
  • [10] Sodium-glucose cotransporter-2 inhibitor-associated thrombocytopenia
    Bando, Hironori
    Hirota, Yushi
    Ogawa, Wataru
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2025, 24 (01): : 165 - 166
12345